Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTB4R | Q15722 | 7/20 | 0.57 |
| ▸ | LTB4R2 | Q9NPC1 | 7/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | PPARD | Q03181 | 3/20 | 0.40 |
| ▸ | DHODH | Q02127 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8564500 | 0.94 | LTB4R (0.65) | LTB4RLTB4R2MAPTMEN1ALDH1A1 | |
| SCHEMBL8418885 | 0.94 | LTB4R (0.65) | LTB4RLTB4R2MAPTMEN1ALDH1A1 | |
| SCHEMBL8418430 | 0.86 | LTB4R (0.52) | LTB4RLTB4R2MAPTMEN1ALDH1A1 | |
| SCHEMBL8565773 | 0.84 | LTB4R (0.53) | LTB4RLTB4R2MEN1ALDH1A1KMT2A | |
| SCHEMBL4961192 | 0.82 | LTB4R (0.49) | LTB4RLTB4R2MAPTMEN1ALDH1A1 | |
| SCHEMBL8420802 | 0.81 | LTB4R (0.46) | LTB4RLTB4R2MAPTMEN1ALDH1A1 | |
| SCHEMBL8422344 | 0.81 | LTB4R (0.53) | LTB4RLTB4R2MAPTL3MBTL1PPARD | |
| SCHEMBL8418898 | 0.81 | LTB4R (0.65) | LTB4RLTB4R2MAPTMEN1ALDH1A1 | |
| SCHEMBL7990788 | 0.80 | LTB4R (0.88) | LTB4RLTB4R2MAPT | |
| SCHEMBL7990784 | 0.80 | LTB4R (0.88) | LTB4RLTB4R2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0942903-A1 | ARYL-SUBSTITUTED ACRYLAMIDES WITH LEUKOTRIENE B4 (LTB-4) RECEPTOR ANTAGONIST ACTIVITY | Novartis AG (CH) | 1999-09-22 | — | — | EP | disclosed |
| WO-1998013347-A1 | ARYL-SUBSTITUTED ACRYLAMIDES WITH LEUKOTRIENE B4 (LTB-4) RECEPTOR ANTAGONIST ACTIVITY | NOVARTIS AG (CH) | 1998-04-02 | — | — | WO | disclosed |